Team:MIT/Parts

From 2014.igem.org

(Difference between revisions)
Line 22: Line 22:
</tr>
</tr>
-
 
+
<tr>
 +
<td>pEXPR hEF1a:Gmab Heavy</td>
 +
<td><a href="url">number</a></td>
 +
</tr>
<!--1-->
<!--1-->
Line 28: Line 31:
<td>Gantenerumab Variable Human Ig-M Light Chain </td>
<td>Gantenerumab Variable Human Ig-M Light Chain </td>
<td><a href="http://parts.igem.org/Part:BBa_K1391001"> BBa_K1391001 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391001"> BBa_K1391001 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR hEF1a:Gmab light</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 34: Line 42:
<td>CD79A</td>
<td>CD79A</td>
<td><a href="http://parts.igem.org/Part:BBa_K1391002"> BBa_K1391002 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391002"> BBa_K1391002 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR hEF1A:CD79A</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 40: Line 53:
<td>CD79B</td>
<td>CD79B</td>
<td><a href="http://parts.igem.org/Part:BBa_K1391003"> BBa_K1391003 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391003"> BBa_K1391003 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR hEF1a:CD79B</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 46: Line 64:
<td>CD79A-TCS-Gal4VP16</td>
<td>CD79A-TCS-Gal4VP16</td>
<td><a href="http://parts.igem.org/Part:BBa_K1391004"> BBa_K1391004 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391004"> BBa_K1391004 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR hEF1a:CD79A-TCS-Gal4VP16</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 52: Line 75:
<td>CD79B-TCS-Gal4VP16</td>
<td>CD79B-TCS-Gal4VP16</td>
<td><a href="http://parts.igem.org/Part:BBa_K1391005"> BBa_K1391005 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391005"> BBa_K1391005 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR hEF1a:CD79B-TCS-Gal4VP16</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 58: Line 86:
<td>Syk</td>
<td>Syk</td>
<td><a href="http://parts.igem.org/Part:BBa_K1391006"> BBa_K1391006 </a></td>
<td><a href="http://parts.igem.org/Part:BBa_K1391006"> BBa_K1391006 </a></td>
 +
</tr>
 +
 +
<tr>
 +
<td>pEXPR TRE:Syk</td>
 +
<td><a href="url">number</a></td>
</tr>
</tr>
Line 66: Line 99:
</tr>
</tr>
 +
<tr>
 +
<td>pEXPR TRE:Syk-TEVp</td>
 +
<td><a href="url">number</a></td>
 +
</tr>
<!--8-->
<!--8-->
<tr>
<tr>
Line 72: Line 109:
</tr>
</tr>
 +
<tr>
 +
<td>pEXPR TRE:Lyn-mKate</td>
 +
<td><a href="url">number</a></td>
 +
</tr>
<!--9-->
<!--9-->
<tr>
<tr>

Revision as of 22:06, 17 October 2014

 


Image Map


Parts


Part

Part Number

Gantenerumab Variable Human Ig-M Heavy Chain BBa_K1391000
pEXPR hEF1a:Gmab Heavy number
Gantenerumab Variable Human Ig-M Light Chain BBa_K1391001
pEXPR hEF1a:Gmab light number
CD79A BBa_K1391002
pEXPR hEF1A:CD79A number
CD79B BBa_K1391003
pEXPR hEF1a:CD79B number
CD79A-TCS-Gal4VP16 BBa_K1391004
pEXPR hEF1a:CD79A-TCS-Gal4VP16 number
CD79B-TCS-Gal4VP16 BBa_K1391005
pEXPR hEF1a:CD79B-TCS-Gal4VP16 number
Syk BBa_K1391006
pEXPR TRE:Syk number
Syk-TEVp BBa_K1391007
pEXPR TRE:Syk-TEVp number
Lyn BBa_K1391008
pEXPR TRE:Lyn-mKate number
Lyn-TEVp BBa_K1391009
pENTR_PirB BBa_K1391010
pENTR_LilrB2 BBa_K1391011
pENTR_Coflin (Inactivated - pseudophosphorylated) BBa_K1391012
pENTR_PirB_TCS_Gal4VP16 BBa_K1391013
pENTR_LilrB2_TCS_Gal4VP16 BBa_K1391014
pENTR_Cofilin(inactivated)_TEVp BBa_K1391015